Showing results (61-70 of 138) with videos related to
Sort By:
Pageof 14
Reviews of Infectious Diseases|July 1, 1983
Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the futureC C Sanders, W E SandersAntimicrobial Agents and Chemotherapy|January 1, 1990
Diverse potential of beta-lactamase inhibitors to induce class I enzymesD A Weber, C C SandersThe Journal of Infectious Diseases|November 1, 1982
Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococciC C Sanders, W E SandersThe Journal of Antimicrobial Chemotherapy|September 17, 1998
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolonesK S Thomson, C C SandersAntimicrobial Agents and Chemotherapy|May 1, 1999
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic modelP D Lister, C C SandersAmerican Journal of Clinical Pathology|March 11, 1975
Effects of procedural variations on the activity of aminoglycosides in vitroC C Sanders, W E SandersThe Journal of Antimicrobial Chemotherapy|June 5, 2001
Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniaeP D Lister, C C SandersAmerican Journal of Clinical Pathology|April 1, 1980
Antagonism of cefamandole by cefoxitin in routine disk susceptibility testsC C Sanders, W E SandersThe Journal of Antibiotics|April 1, 1978
Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in miceR V Goering, C C Sanders, W SandersAntimicrobial Agents and Chemotherapy|July 1, 1991
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymesS J Cavalieri, C C Sanders, C NewPageof 14